(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 16.13% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.28%.
Natera's revenue in 2025 is $1,831,000,000.On average, 24 Wall Street analysts forecast NTRA's revenue for 2025 to be $291,253,855,140, with the lowest NTRA revenue forecast at $274,458,625,800, and the highest NTRA revenue forecast at $303,133,407,600. On average, 24 Wall Street analysts forecast NTRA's revenue for 2026 to be $336,177,679,960, with the lowest NTRA revenue forecast at $311,326,202,400, and the highest NTRA revenue forecast at $368,675,766,000.
In 2027, NTRA is forecast to generate $394,073,429,880 in revenue, with the lowest revenue forecast at $339,727,891,040 and the highest revenue forecast at $446,507,316,600.